Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity

Clin Res Hepatol Gastroenterol. 2021 May;45(3):101472. doi: 10.1016/j.clinre.2020.05.020. Epub 2020 Jun 18.

¹ Pediatric Hepatology and Liver Transplantation Unit, National Reference Centre for Biliary Atresia and Genetic Cholestasis, FILFOIE, ERN RARE LIVER, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, 78, rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France.
² Pediatric Hepatology and Liver Transplantation Unit, National Reference Centre for Biliary Atresia and Genetic Cholestasis, FILFOIE, ERN RARE LIVER, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, University Paris-Saclay, 78, rue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France; INSERM U1193, Hepatinov, University Paris-Saclay, Orsay, France. Electronic address: emmanuel.jacquemin@aphp.fr.

No abstract available

Keywords: Alagille syndrome; Biliary atresia; Gestation; Liver transplantation; Teratogenicity; UDCA.

MeSH terms